Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes

被引：0
|
作者：
Robert Krysiak
Boguslaw Okopień
Zbigniew S. Herman
机构：
[1] Medical University of Silesia,Department of Clinical Pharmacology
来源：
Drugs | 2003年 / 63卷
关键词：
Simvastatin; Atorvastatin; Pravastatin; Human Umbilical Vein Endothelial Cell; Tissue Factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent large clinical trials have demonstrated that HMG-CoA reductase inhibitors, or statins, markedly reduce morbidity and mortality when used in the primary and secondary prevention of cardiovascular disease. It has been established that the benefits of statin therapy in cardiovascular disease can be explained not only by the lipid-lowering potential of statins but also by nonlipid-related mechanisms (so-called ‘pleiotropic effects’) that contribute to the positive effect of statins on the incidence of cardiovascular events.
引用
收藏
页码：1821 / 1854
页数：33
相关论文
共 50 条
  • [1] Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes
    Krysiak, R
    Okopien, B
    Herman, ZS
    DRUGS, 2003, 63 (17) : 1821 - 1854
  • [2] The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration
    Saravi, Seyed Soheil Saeedi
    Saravi, Seyed Sobhan Saeedi
    Arefidoust, Alireza
    Dehpour, Ahmad Reza
    METABOLIC BRAIN DISEASE, 2017, 32 (04) : 949 - 965
  • [3] The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration
    Seyed Soheil Saeedi Saravi
    Seyed Sobhan Saeedi Saravi
    Alireza Arefidoust
    Ahmad Reza Dehpour
    Metabolic Brain Disease, 2017, 32 : 949 - 965
  • [4] HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1985, 183 : 295 - 310
  • [5] HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    HASUMI, K
    NATURAL PRODUCT REPORTS, 1993, 10 (06) : 541 - 550
  • [6] HMG-COA REDUCTASE INHIBITORS
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1988, 40 (06): : 477 - 477
  • [7] Immunomodulatory effects of HMG-CoA reductase inhibitors
    Danesh, FR
    Anel, RL
    Zeng, LX
    Lomasney, J
    Sahai, A
    Kanwar, YS
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2003, 51 (03) : 139 - 148
  • [8] HMG-CoA reductase inhibitors
    Illingworth, DR
    Tobert, JA
    ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 77 - 114
  • [9] HMG-COA REDUCTASE INHIBITORS
    GRUNDY, SM
    JOURNAL OF INTERNAL MEDICINE, 1990, 228 (03) : 201 - 205
  • [10] Pleiotropic effects of HMG-CoA reductase inhibitors
    Nikos Werner
    Georg Nickenig
    Ulrich Laufs
    Basic Research in Cardiology, 2002, 97 : 105 - 116
12345